Nvidia’s NVDA2.03%increase; green up pointing triangle licensing deal with startup Groq is a sign of growing competition for top talent and technology on the next front of the AI war: inference. The ...
PRINCETON, N.J. and HANGZHOU, China, Dec. 28, 2025 (GLOBE NEWSWIRE) -- Transcenta Holding Limited (HKEX: 06628) (“Transcenta Therapeutics”), a global clinical stage biopharmaceutical company with ...
SAN JOSE, Calif., Dec. 22, 2025 (GLOBE NEWSWIRE) -- Adeia Inc. (Nasdaq: ADEA), the technology company known for developing foundational innovations that enable next-generation solutions for the ...
"When an attorney leaves a firm, there are rules in our profession, where every client that I was representing should have had an opportunity to pick Ken Nugent or Eric Sterling," Sterling said during ...
Sagimet Biosciences shares rose after the company said it had entered into a global licensing agreement. The stock rose 13% to $6.83 on Wednesday. Shares are up 48% this year. The San Mateo, Calif., ...
Walt Disney Co. is investing $1 billion in OpenAI under a new commercial partnership with the ChatGPT and Sora developer. The three-year licensing agreement will allow users of Sora, OpenAI's ...
Disney and OpenAI struck a licensing agreement that gives ChatGPT and Sora access to Disney's characters and IP. Disney is also investing $1 billion in the AI company and becoming a "major customer." ...
Disney characters are coming to OpenAI’s Sora video generation app — this time, with permission. OpenAI and Disney just announced a “landmark agreement” that will see some Sora content appear on ...
Lupin has inked an agreement with Valorum for biosimilar Armlupeg. Pegfilgrastim-unne is indicated to reduce the duration of neutropenia and the incidence of febrile neutropenia in patients receiving ...
Disney will make a $1 billion equity investment in OpenAI and receive warrants to purchase additional equity. FDA intends to put its most serious warning on COVID vaccines, sources say California home ...
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) today announced it has entered into an exclusive global collaboration and license agreement with YaoPharma, a subsidiary of Shanghai Fosun ...
Suit Alleges King & Spalding Coerced Ex-Client Into Lit Funding Agreement Amid 'Massive Overbilling'
A Chicago business owner, in malpractice lawsuit, claims King & Spalding "engaged in massive overbilling and mismanagement.” It also alleges the firm pressured him to borrow from a litigation funding ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback